53 results
P
women in the Middle East and North Africa (MENA) region
I/C
O
prevalence of gestational diabetes mellitus (GDM)
P
North America, Europe, Asia, Latin America, Middle East
I/C
carbohydrate intake, fat consumption, protein intake, saturated fatty acid intake
O
decreased carbohydrate and increased fat and protein intake, regional variations in dietary trends
P
North America, Europe, Asia, Oceania
I/C
obesity, non-obese
O
PLC-related mortality
P
North Americans
I/C
Exposure to outdoor air pollution, Low concentrations of particulate matter with an aerodynamic diameter of less than 2.5 μm (PM2.5) vs. current European Union (EU) Limit Values, U.S. Environmental Protection Agency (U.S. EPA), National Ambient Air Quality Standards (NAAQS), and/or World Health Organization (WHO) Air Quality Guideline values for PM2.5
O
Morbidity and mortality endpoints
P
African populations
I/C
systematic review and meta-analysis, North Africa vs. Sub-Saharan Africa
O
prevalence rates of mental health symptoms
P
dogs
I/C
North America countries, other high income countries
O
seroprevalence estimates
P
Asian-Pacific population, European population, North American population
I/C
EQ-5D questionnaires, EQ VAS, construct validity studies, test-retest reliability studies, responsiveness studies
O
sufficient construct validity, sufficient test-retest reliability, sufficient responsiveness
P
817 babies
I/C
BCG vaccination, 21 studies
O
Incidence of BCG lymphadenitis
P
children and adolescents with Duchenne muscular dystrophy (DMD)
I/C
pharmacological treatments that increase the synthesis of dystrophin, placebo or no treatment
O
6-minute walking distance (6MWD), other timed functional tests (TFTs), The North Star Ambulatory Assessment, dystrophin expression, cardiorespiratory function, and biochemical tests
P
children
I/C
primary teeth, eruption timing
O
advanced/delayed eruption